Organon & Co.
OGN · Pharmaceutical Preparations
Latest available SEC filing: 4 ·
Latest disclosures
-
Arjona Ferreira Juan Camilo: Form 4
Insider disclosure · Filed · Report period 11 Aug 2026
-
Form 4
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- OGN · 68622V106 - Common Stock, par value $0.01 per share
Company details and SEC sources
CIK 0001821825 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- OGN on NYSE
- SEC industry group
- Pharmaceutical Preparations (Office of Life Sciences)
- Business address
- 30 Hudson Street, Fl 33, Jersey City, NJ, 07302
- Fiscal year end
- 31 December
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields